Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the promotion of Sanam Pangali to ...

Lolo Lekgoane’s life changed when she was diagnosed with systemic lupus erythematosus. The Mahikeng resident faced immense challenges, including giving up her job, losing mobility and enduring ...

Viewing lupus decision aids without interruption leads to better patient-reported outcomes, regardless of whether they are ...

Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

The thymus functions as the primary lymphoid organ responsible for the generation of T cells and plays a crucial role in preventing autoimmune reactions by eliminating autoreactive cells before ...

You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...

For individuals with specific autoimmune conditions, there appears to be an increased risk for affective disorders.

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

Incorporating systemic lupus erythematosus disease activity score (SLEDAS) criteria may enhance treat-to-target strategies ...

Meanwhile, RemeGen can acquire around 23% of Vor Bio's enlarged issued share capital through the $80 million in warrants, in ...

The incidence and prevalence of CTD-ILD in the US is most common among women and older individuals, affecting approximately 116,000 to 118,000 adults.

Magnetic resonance imaging (MRI) findings such as inflammatory-type lesions and myelopathies are significantly associated with attribution of neuropsychiatric (NP) events to systemic lupus ...